Sobi to acquire Arthrosi Therapeutics

Sobi (Swedish Orphan Biovitrum) has entered into a definitive agreement to acquire San Diego-based biotech Arthrosi Therapeutics. Arthrosi is focused on developing a next-generation treatment for gout.